CVS Warns Broader Cost Controls Coming As Economic Downturn Collides With Costly New Therapies
Executive Summary
CVS Caremark's Lotvin reports increased US payer interest in more comprehensive drug management solutions and that some payers are asking about dropping coverage for drug categories.